TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/11/24 18:00 | 4/9/24 | AVTE | Aerovate Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grayzel David S. | MA | D | S | -334 | 28.15 | 0 | -12 | -1 | 1,799 | I | |||||||||||||||
7/6/21 16:27 | 7/2/21 | AVTE | Aerovate Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grayzel David S. | MA | D | P.d | 7,500 | 14.00 | 0 | 536 | 21 | 3,104 | I | |||||||||||||||
12/21/20 15:35 | 12/17/20 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Grayzel David S. | MA | D | S.a | -13,770 | 8.10 | 0 | -1,700 | -37 | 2,945 | I | |||||||||||||||
12/21/20 13:32 | 12/17/20 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Grayzel David S. | MA | D | S | -30,770 | 18.10 | 0 | -1,700 | -37 | 2,945 | I | |||||||||||||||
4/23/18 16:18 | 4/23/18 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Grayzel David S. | MA | D | P.d | 1,500 | 15.00 | 0 | 100 | 2 | 4,645 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |